We have observed
5 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after November 30, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
A COMPOSITION FOR THE TREATMENT AND PREVENTION OF URINARY TRACT INFECTIONS
A COMPOSITION HAVING A MUSCLE-RELAXANT AND ANTI-INFLAMMATORY ACTIVITY
A COMPOSITION FOR THE TREATMENT OF ARTHROPATHIES AND OSTEOARTHRITIS
A COMPOSITION FOR THE TREATMENT OF NEUROPATHIES AND/OR NEUROPATHIC PAIN
THE USE OF PHOSPHATIDYLSERINE FOR THE PREVENTION AND TREATMENT OF PROSTATE DISORDERS, AND THE CORRESPONDING PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS